Real-time enrollment status for this gbm clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 9:02 AM UTC
| NCT Number | NCT05086497 |
| Recruiting Status | Recruiting |
| Condition | GBM |
| Phase | NA |
| Target Enrollment | 155 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | August 6, 2026 (4 weeks ago) |
As of September 3, 2026: Clinical trial NCT05086497 is currently recruiting participants. This na study for gbm is actively seeking new participants at 2 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05086497 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05086497 was last updated 4 weeks ago (August 6, 2026). HelloStudys verifies this status automatically.